Evidence map›Paper›PMID 42541501›Full record

ArticleJACC. Asia2026

Prognosis by Renal Function With or Without Percutaneous Coronary Intervention in Non-ST-Segment Elevation Myocardial Infarction.

Yong Hoon Kim, Ae-Young Her, Seung-Woon Rha, Cheol Ung Choi, Byoung Geol Choi, Jung Rae Cho, Min-Woong Kim, Ji Young Park, Eun-Seok Shin, Ju Han Kim and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yong Hoon KimDivision of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Chuncheon, Republic of Korea; Division of Cardiology, Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea. Electronic address: yhkim02@kangwon.ac.kr.
Ae-Young HerDivision of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Chuncheon, Republic of Korea; Division of Cardiology, Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
Seung-Woon RhaCardiovascular Center, Korea University Guro Hospital, Seoul, Republic of Korea. Electronic address: swrha617@yahoo.co.kr.
Cheol Ung ChoiCardiovascular Center, Korea University Guro Hospital, Seoul, Republic of Korea.
Byoung Geol ChoiDepartment of Biomedical Laboratory Science, Honam University, Gwangju, Republic of Korea.
Jung Rae ChoCardiology Division, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
Min-Woong KimDepartment of Cardiology, Changwon Hanmaeum Hospital, Hanyang University College of Medicine, Changwon, Republic of Korea.
Ji Young ParkDivision of Cardiology, Department of Internal Medicine, Cardiovascular Center, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea.
Eun-Seok ShinDivision of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
Ju Han KimDivision of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
Youngkeun AhnDivision of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
Hyo-Soo KimCardiovascular Center, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Myung Ho JeongDepartment of Cardiology, Cardiovascular Center, Chonnam National University Hospital, Gwangju, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal dysfunction increases adverse outcomes in non-ST-segment elevation myocardial infarction (NSTEMI), but evidence comparing percutaneous coronary intervention (PCI) with non-PCI by renal function is limited.

objectivesThe authors aimed to compare 3-year outcomes of PCI versus non-PCI by baseline renal function in NSTEMI.

methodsWe stratified 15,255 NSTEMI patients by estimated glomerular filtration rate (eGFR; ≥90, 60-89, 30-59, and <30 mL/min/1.73 m

resultsWorsening renal function was associated with higher MACCE and mortality (all P < 0.001), except between eGFR ≥90 and 60-89. Compared with non-PCI, PCI was associated with lower adjusted risks in the eGFR 60-89, 30-59, and <30 strata, respectively, regarding MACCE (HR [95% CI]: 0.58 [0.47-0.71]; 0.66 [0.53-0.82]; 0.60 [0.48-0.75]), all-cause mortality (HR [95% CI]: 0.47 [0.37-0.60]; 0.57 [0.45-0.72]; 0.59 [0.47-0.76]), and cardiovascular mortality (HR [95% CI]: 0.48 [0.34-0.66]; 0.53 [0.39-0.70]; 0.56 [0.41-0.75]) (all P < 0.001), but not in eGFR ≥90 MACCE (HR: 0.83 [95% CI: 0.64-1.07]; P = 0.158). Significant interaction was observed only for all-cause mortality (P = 0.044).

conclusionsIn NSTEMI, worsening renal function was associated with higher long-term adverse outcomes. PCI was associated with lower risks across most renal function strata, but not in eGFR ≥90.

Indexed as

glomerular filtration ratemyocardial infarctionnon–ST-segment elevationtreatment outcome

Identifiers

PMID42541501
PMCPMC13554772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.